EUGENIE S KLEINERMAN to Immunotherapy
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Immunotherapy.
Connection Strength
0.098
-
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression. Mol Ther. 2009 Oct; 17(10):1779-87.
Score: 0.033
-
Biologic response modifiers in pediatric cancer. Hematol Oncol Clin North Am. 2001 Aug; 15(4):723-40, ix.
Score: 0.019
-
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells. J Immunother Cancer. 2020 04; 8(1).
Score: 0.018
-
CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors. Mol Cancer. 2014 Feb 24; 13:34.
Score: 0.012
-
Liposomal MTP-PE for the adjuvant therapy of osteosarcoma. Prog Clin Biol Res. 1990; 343:263-79.
Score: 0.009
-
Production and utilization of human lymphokines containing macrophage-activating factor (MAF) activity. Lymphokine Res. 1983; 2(1):7-12.
Score: 0.005
-
Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients. J Clin Oncol. 1989 Dec; 7(12):1915-25.
Score: 0.002